Healthy Participant Population Demographics, MR Imaging Findings, and 18F-GE-179 Injection Data
| Patient identification no. | Age (y) | Sex | Weight (kg) | Handedness | Smoker | MR imaging | Injected dose (MBq) | Specific activity at time of injection (GBq/μmol) | Purity (%) | Coinjected mass (μg) |
| 1 | 26 | M | 80 | L | No | Normal | 187.0 | 450.1 | 98 | 0.16 |
| 2 | 31 | M | 67 | R | No | Normal | 173.2 | 73.1 | 97 | 0.91 |
| 3 | 55 | M | 83 | R | Yes | WM foci | 186.0 | 1428.0 | 97 | 0.05 |
| 4 | 37 | F | 58 | R | No | Tiny WM foci | 180.4 | 769.5 | 96 | 0.09 |
| 5 | 61 | M | 65 | R | No | Normal | 183.7 | 881.5 | 95 | 0.08 |
| 6 | 62 | F | 53 | R | No | WM foci | 185.3 | 229.5 | 96 | 0.31 |
| 7* | 25 | F | 81 | R | No | Normal | 192.4 | 263.8 | 96 | 0.28 |
| 8 | 26 | M | 91 | L | No | Normal | 189.2 | 726.6 | 96 | 0.10 |
| 9 | 57 | M | 84 | R | No | RF WM foci | 186.9 | 311.9 | 96 | 0.23 |
| Median/total | 37 | 6 M | 80 | 7 right | 1 smoker | NA | 186.0 | 450.1 | 96 | 0.16 |
| CV (%) | 17 | 2.8 | 70.0 | 1 | 102 | |||||
| IQR | 26–57 | 65–83 | 183.7–187.0 | 263.8–769.5 | 96–97 | 0.09–0.28 | ||||
| Minimum | 25 | 53 | 173.2 | 73.1 | 95 | 0.05 | ||||
| Maximum | 62 | 91 | 192.4 | 1428.0 | 98 | 0.91 |
↵* Participant 7 was a regular user of ibuprofen. Analysis by ANOVA failed to demonstrate any significant influence of this variable on AUCmetabs or AUCIF.
WM = white matter; RF = right frontal; NA = nonapplicable.